SCHEMBL18292638

SCHEMBL18292638

O=NCc1cc(CN=O)cc(N=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18970300 0.95 — —
SCHEMBL17366364 0.86 — —
SCHEMBL19826377 0.84 ACHE (0.34) —
SCHEMBL24080830 0.74 PGK1 (0.43) —
SCHEMBL22273431 0.74 ALDH1A1 (0.35) —
SCHEMBL17506714 0.74 ACHE (0.42) —
SCHEMBL11287516 0.74 ALDH1A1 (0.41) —
SCHEMBL18292655 0.74 — —
SCHEMBL18292827 0.74 ACHE (0.42) —
SCHEMBL17230076 0.70 GRIN2B (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3100745-A1 NOVEL BENZODIAZEPINE DERIVATIVES Immunogen, Inc. (US) 2016-12-07 — — EP disclosed
Send feedback